BELLEVUE, Wash.--(BUSINESS WIRE)--Oct. 27, 2005--SCOLR Pharma, Inc. (AMEX:DDD) announced today that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC), pursuant to which SCOLR Pharma may sell, from time to time, up to $40 million in common stock and/or common stock purchase warrants. The terms of any future offering would be established at the time of the offering, and announced in a filing with the SEC.
